Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

12.5%

1 terminated out of 8 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed with results

Key Signals

2 with results80% success

Data Visualizations

Phase Distribution

4Total

Not Applicable (2)

P 4 (2)

Trial Status

Completed4

Unknown2

Not Yet Recruiting1

Terminated1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT04969874Not ApplicableNot Yet RecruitingPrimary

Remote Orthophonic Follow-up on Patients with Chronic Swallowing Disorders

NCT06742034Completed

Translation and Validation of the Visual Analysis of Swallowing Efficiency and Safety Into European Portuguese

NCT04114617CompletedPrimary

Physiological Flow of Liquids in Healthy Swallowing

NCT05452135Unknown

Cognitive - Motor Dual Task and Swallowing

NCT03705936Not ApplicableCompletedPrimary

Metaplasticity in Human Pharyngeal Motor Cortex

NCT03588806Phase 4Terminated

Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills

NCT03390972Phase 4UnknownPrimary

Dexmedetomidine and Swallowing Function

NCT00475943CompletedPrimary

Movement of Epiglottis During Swallowing

Showing all 8 trials

DEGLUTİTİON